| Oct 31 |
Equillium says Ono not acquiring itolizumab, stock craters 36%
|
| Oct 31 |
Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
|
| Oct 31 |
Equillium Maintains Rights to Itolizumab Following Ono Partnership
|
| Oct 31 |
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
| Oct 22 |
Alto Ingredients And 2 Other US Penny Stocks To Watch Closely
|
| Oct 7 |
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
|
| Sep 17 |
Equillium collaborates with Vivtex for oral formulation of autoimmune therapy
|
| Sep 10 |
Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
|
| Aug 28 |
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
|
| Aug 11 |
Equillium Second Quarter 2024 Earnings: Beats Expectations
|
